Transcatheter interventions for valvular heart diseases in liver cirrhosis patients.
Ahmed T, Misumida N, Grigorian A, Tarantini G, Messerli AW.
Trends Cardiovasc Med. 2023 May;33(4):242-249. doi: 10.1016/j.tcm.2021.12.014. Epub 2021 Dec 30.
Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.
Patel NJ, Bavishi C, Atti V, Tripathi A, Nalluri N, Cohen MG, Kini AS, Sharma SK, Dangas G, Bhatt DL.
Circ Cardiovasc Interv. 2018 Nov;11(11):e007045. doi: 10.1161/CIRCINTERVENTIONS.118.007045.
Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S, Panchal HB, Bagai J, Banerjee S, Brilakis ES, Mukherjee D, Kumar G, Shanmugasundaram M, Paul TK.
Cardiovasc Revasc Med. 2019 Sep;20(9):758-767. doi: 10.1016/j.carrev.2018.11.013. Epub 2018 Nov 22.
Systematic review of native and graft-related aortic infection outcome managed with orthotopic xenopericardial grafts.
Hostalrich A, Ozdemir BA, Sfeir J, Solovei L, Alric P, Canaud L.
J Vasc Surg. 2019 Feb;69(2):614-618. doi: 10.1016/j.jvs.2018.07.072. Epub 2018 Oct 24.
A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy.
Texakalidis P, Giannopoulos S, Charisis N, Giannopoulos S, Karasavvidis T, Koullias G, Jabbour P.
J Vasc Surg. 2018 Oct;68(4):1241-1256.e1. doi: 10.1016/j.jvs.2018.07.023.
Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
Ha FJ, Nogic J, Montone RA, Cameron JD, Nerlekar N, Brown AJ.
Cardiovasc Revasc Med. 2018 Oct-Nov;19(7 Pt B):837-844. doi: 10.1016/j.carrev.2018.03.025. Epub 2018 Apr 3.
Long-Term Outcomes of Patients Undergoing the Ross Procedure.
Aboud A, Charitos EI, Fujita B, Stierle U, Reil JC, Voth V, Liebrich M, Andreas M, Holubec T, Bening C, Albert M, Fila P, Ondrasek J, Murin P, Lange R, Reichenspurner H, Franke U, Gorski A, Moritz A, Laufer G, Hemmer W, Sievers HH, Ensminger S.
J Am Coll Cardiol. 2021 Mar 23;77(11):1412-1422. doi: 10.1016/j.jacc.2021.01.034.
First experiences with HeartMate 3 follow-up and adverse events.
Hanke JS, Dogan G, Rojas SV, Zoch A, Feldmann C, Deniz E, Avsar M, Warnecke G, Haverich A, Schmitto JD.
J Thorac Cardiovasc Surg. 2017 Jul;154(1):173-178. doi: 10.1016/j.jtcvs.2017.01.045. Epub 2017 Feb 9.
A comprehensive meta-analysis of randomized controlled trials comparing drug-eluting stents with bare-metal stents in saphenous vein graft interventions.
Shah R, Jovin IS, Latham SB, Hesterberg K, Heckle MR, Rashid A, Vetrovec GW.
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1229-1236. doi: 10.1002/ccd.27687. Epub 2018 Jul 26.
Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.
Frontera JA, Starling R, Cho SM, Nowacki AS, Uchino K, Hussain MS, Mountis M, Moazami N.
J Heart Lung Transplant. 2017 Jun;36(6):673-683. doi: 10.1016/j.healun.2016.12.010. Epub 2016 Dec 23.
